Fatih Aktoz

Dr. Fatih Aktoz


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2022 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
FAFatih Aktoz
Fatih Aktoz
CTCan Tercan
Can Tercan
EDEmrah Dagdeviren
Emrah Dagdeviren
CKCihan Kaya
Cihan Kaya

7 October 2023 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
FAFatih Aktoz
Fatih Aktoz
AGAli Can Gunes
Ali Can Gunes
KYKayhan Yakin
Kayhan Yakin

4 June 2018 in Journal of the Turkish-German Gynecological Association
Verified
Journal Article
Closed access
KBKemal Beksaç
Kemal Beksaç
FAFatih Aktoz
Fatih Aktoz
GOGokcen Orgul
Gokcen Orgul
HÇHasan Tolga Çelik
Hasan Tolga Çelik
AOA.Seval Ozgu-Erdinc
A.Seval Ozgu-Erdinc
MBMehmet Sinan Beksac
Mehmet Sinan Beksac
Pregnancy in Papillary Thyroid Cancer Survivors

20 September 2018 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
FAFatih Aktoz
Fatih Aktoz
AYAnil Can Yalcin
Anil Can Yalcin
HYHasan Salih Yüzdemir
Hasan Salih Yüzdemir
DADeniz Akata
Deniz Akata
MGMurat Gültekin
Murat Gültekin
Background: Metastatic breast cancer diagnosis is the most common malignancy in pregnancy and the incidence of it has been increasing among the pregnant women due to advancing maternal age within the populations. However, there are limited data about the use of trastuzumab during pregnancy with conflicting results. Case history: A 37-year-old pregnant female patient was admitted to our hospital with the metastatic breast cancer diagnosis. An MRI study showed metastatic solid masses in all lobes and segments of the patient’s liver. Patient was treated with weekly docetaxel and trastuzumab regimen from 22 to 34 weeks and labored electively at the 35th gestational week. Antenatal follow-up of the fetus showed all normal ranges without any complications. An abdominal MRI following the labor revealed complete clearance of liver metastasis. Conclusions: Use of trastuzumab during pregnancy is debated due to the limited number of cases reported in the literature. This article gives a summary of the existing data where the outcome was a complete remission in disease with normal fetal development during pregnancy

24 August 2024 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
CTCan Tercan
Can Tercan
AGAli Can Gunes
Ali Can Gunes
EBErcan Bastu
Ercan Bastu
CBChristophe Blockeel
Christophe Blockeel
FAFatih Aktoz
Fatih Aktoz

20 March 2019 in Fetal and Pediatric Pathology
Verified
Journal Article
Closed access
FAFatih Aktoz
Fatih Aktoz
OOOzgur Ozyuncu
Ozgur Ozyuncu
ATAtakan Tanaçan
Atakan Tanaçan
EFErdem Fadiloglu
Erdem Fadiloglu
CUCanan Unal
Canan Unal
MBMehmet Sinan Beksac
Mehmet Sinan Beksac
Objective: To evaluate and compare the outcomes of pregnancies with prenatally detected gastroschisis and omphalocele. Materials and Methods: We retrospectively evaluated prenatally detected gastroschisis and omphalocele cases. Cases were compared in terms of maternal demographic and clinical characteristics as well as pregnancy and neonatal outcomes. Results: This study consisted of 17 gastroschisis and 30 omphalocele cases. Only one case with gastroschisis was terminated due to additional severe limb deformities. Seventeen out of 30 cases of omphalocele were terminated for various reasons (56.7%). All patients with gastroschisis had surgical repair, while 8 out of 13 omphalocele cases had surgery. One patient with an omphalocele died after surgery due to sepsis. Six cases of gastroschisis also died in the neonatal period due to various reasons (6/16, 37.5%). Conclusion: Additional genetic disorders are more frequent in those with omphalocele cases, and they are more frequently terminated during gestation that the gastroschisis fetuses.